|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| ePharma: The Online Pharmaceutical Industry, 2006-2011 |
|
|
|
|
€ 2 219,00 |
Editeur
: |
Visiongain |
Langue
: |
Anglais |
Date de publication : |
Juillet 2006 |
Taille du document : |
171 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (2) |
|
|
|
| 56 pages | Février 2007 | Anglais
|
|
|
| Main
focus: |
pharmaceutical,pharmaceutical industry,...,...
|
| Research
focus: |
pricing policy,market definition, |
| Geographic
focus: |
australia,france,usa,spain,ireland,italy,... |
| |
|
|
|
|
| 158 pages | Juin 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceutical,pharmaceutical industry,...,...
|
| Research
focus: |
industry structure,distribution channels, |
| Geographic
focus: |
usa,france,china,italy,japan,united kingdom,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Pfizer's Recent Takeover
15 pages | Juillet 2002 |
On 15th July 2002, Pfizer announced the acquisition of Pharmacia in a stock-for-stock transaction valued at $60 billion, expanding the company's core strengths in pharmaceuticals and health care.
|
300,00 €
|
| |
| |
Healthcare In Northern Ireland
52 pages | Mai 2000 |
The Northern Ireland Presentation Includes:- The Structure Of The Health Service In Northern Ireland- Total Expenditure On Health & Personal Social Services- Number Of Inpatient Beds, BY Area- Occ |
327,00 €
|
| |
| |
The Pharmaceutical Mergers and Acquisitions Outlook 2001
128 pages | Octobre 2001 |
Pharmaceutical companies have recently undertaken extensive M&A activity to either build critical mass, create organic growth or through strategic alliances to build virtual mass.
The Pharmaceu |
1 200,00 €
|
| |
| |
Pharmaceutical Mergers & Aquisitions: the third wave
160 pages | Février 1999 |
Historical assessment : The report identifies the factors that have driven the two historical waves of M&A activity, and analyses the relative importance of these factors through case studies.
795,00 €
|
|
| |
| |
Pain Therapeutics: A Strategic Re-evaluation.
198 pages | Août 2000 |
Pain management, though not a life-threatening disease, will have its proper place in the future healthcare system because the disability and economic loss in addition to personal suffering caused |
955,00 €
|
| |
| |
Global Pharmaceutical: a market, company and disease analysis
150 pages | Octobre 1998 |
What will drive pharmaceutical market growth into the 21st Century? What are the key challenges facing pharmaceutical manufacturers? Who are the market leaders in each sector? What strategies ar |
795,00 €
|
| |
| |
Healthcare: Germany
106 pages | Octobre 2000 |
Compare the changes in expenditure between the different healthcare sectors in Germany · Understand the main factors affecting demand for healthcare services in Germany · Examine the |
578,54 €
|
| |
| |
Healthcare In Scotland
52 pages | Mai 2000 |
The Scottish Presentation Includes:- The Structure Of The NHS In Scotland- The Funding Of The NHS In Scotland- Distribution Of The NHS Budget In Scotland- Segmentation Of Expenditure - Total Capital E |
327,00 €
|
| |
| |
The Cardiovascular Outlook 1998-2010
186 pages | Août 1999 |
In 1998, the global cardiovascular market expanded by 7.2%, growing in value from $60bn in 1997 to almost $65bn in 1998.
Market expansion is being driven by expanding prevalent populations in t |
795,00 €
|
| |
| |
Healthcare In Southern Ireland
40 pages | Mai 2000 |
The Republic Of Ireland Presentation Includes:- The Structure Of The Health Service In The Republic Of Ireland- Capital Expenditure On Health Care In The Republic Of Ireland- Number Of Publicly Funded |
327,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| ePharma: The Online Pharmaceutical Industry, 2006-2011 |
|
|
The purpose of this visiongain report is to examine the commercial prospects of online technologies in the pharmaceutical sector. In particular, this report examines the fast-growing fields of pharmaceutical eMarketing, eDetailing, ePrescribing and online drug sales. Online technological solutions have great potential to benefit - even revolutionise – the marketing efforts of drug companies. Visiongain predicts that all aspects of pharmaceutical eMarketing will exhibit steady growth from 2006-2011. Key technological solutions - such as Internet-enabled DTC promotion, eDetailing and ePrescribing - will drive that expansion. Sales of prescription drugs via the Internet will also be significant.
ePharma: The Online Pharmaceutical Industry, 2006-2011 examines this burgeoning new method of marketing and the selling of drugs online through comprehensive primary and secondary research. In addition to consultation with experts in eMarketing and ePrescribing, the research involved a detailed study of policy documents, industrial reports and relevant news. Importantly, Visiongain also applied techniques such as financial forecasting, SWOT analyses and qualitative projections. The result is a comprehensive market-based report with detailed analysis and informed opinion.
In particular, this report concentrates on the following essential aspects of online solutions in the pharmaceutical sector:
Technologies that drive the online pharmaceutical sector
Key players in eMarketing and ePrescribing – both providers of technology and leading users of these solutions or platforms
Forecasts of key metrics in eMarketing, ePrescribing and online drug sales from 2006-2011
Drivers and opportunities in pharmaceutical eMarketing, both to consumers and medical professionals
Restraints and threats in pharmaceutical eMarketing
Regulatory issues in pharmaceutical eMarketing, ePrescribing and online drug sales
Comprehensive assessments of relevant business models, technological solutions and associated issues
Why you should buy this report:
To receive a comprehensive analysis of the prospects for online solutions in pharmaceutical sales, marketing and prescribing from 2006-2011
To discover predicted investments, growth rates and other key metrics for online pharmaceutical solutions from 2006-2011
To determine the forces that influence pharmaceutical eMarketing, ePrescribing and online drug sales: - Competitive characteristics of the marketRegulatory, technological and societal issues - Drivers and restraints - Strengths, weaknesses, opportunities and threats
To find out where pharmaceutical eMarketing, ePrescribing and online drug sales are heading - both technologically and commercially
|
|
ePharma: The Online Pharmaceutical Industry, 2006-2011
|
|
|
PPLSEN
|
|
|
|
|
